Editorial
Metformin: a potentially winning therapeutic strategy to prevent breast cancer progression in overweight postmenopausal patients
Abstract
Growing body of literature supports the evidence that, in postmenopausal women, breast cancer initiation and progression are close associated with a series of interconnected factors which include weight gain, metabolic syndrome and increase of circulating androgens.
